Skip Navigation

Lung cancer (non-small-cell) - pemetrexed

Pemetrexed for the treatment of non-small-cell lung cancer

Guidance type:  Technology appraisal
Date issued:  August 2007

We will consult on our review plans for this guidance in January 2010.

Reference:  TA124

Summary

  • Pemetrexed is not recommended for the treatment of locally advanced or metastatic non-small-cell lung cancer.
  • People currently receiving pemetrexed should have the option to continue therapy until they and their clinicians consider it appropriate to stop.
Top

Documents

For healthcare professionals

For patients, carers and the public

Background information

Implementing this guidance

Any further information NICE has produced to help the NHS implement this guideline locally is linked to below:

Top

Search NICE guidance


Advanced guidance search

Related guidance

Click the links below to see guidance on similar topics